This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent. Top assignees: Laboratorios Farmaceuticos Rovi S.a., Laboratorios Farmacéutios Rovi, S.a.. Active years: 2012-2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 33 
1 out of 1 Years Active: 2012-2014
Title: The Innovations of Ivan Lopez-Belmonte Encina: Pioneering Synthesis in Pharmaceuticals
Introduction: Ivan Lopez-Belmonte Encina, an accomplished inventor based in Madrid, Spain, has made significant contributions to the pharmaceutical industry. With two patents to his name, his innovative work has facilitated advancements in drug synthesis and delivery.
Latest Patents: Ivan's latest patents include a breakthrough process for the synthesis of unprotected pentasaccharides from a protected pentasaccharide precursor. This procedure involves five stages, including N-sulphation of amino groups and hydrogenolysis of benzyl groups, which leads to a drastic reduction in total synthesis time compared to traditional methods. This innovation not only improves efficiency but also enhances reproducibility, allowing for standardization in pharmaceutical applications.
The second patent focuses on pharmaceutical forms for the release of active compounds. It describes a formulation containing at least one active compound and a polymeric matrix comprising cationic and biodegradable polymers. This advancement enhances the absorption of active compounds across the mucosa, representing a promising development in drug delivery systems.
Career Highlights: Throughout his career, Ivan has worked with notable companies such as Laboratorios Farmacéuticos Rovi S.A., where he applied his expertise in pharmaceutical innovation. His work has significantly impacted the efficiency and effectiveness of drug synthesis and formulations.
Collaborations: Ivan has collaborated with esteemed coworkers, including Ibon Gutierro Aduriz and Philippe Maincent. These partnerships have contributed to his inventive processes and further advanced the field of pharmaceutical research.
Conclusion: Ivan Lopez-Belmonte Encina continues to push the boundaries of pharmaceutical innovation through his groundbreaking patents. His work exemplifies the importance of continuous advancement in drug synthesis and delivery, ultimately improving patient outcomes in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile